Literature DB >> 17465475

Prevalence and risk factors of asymptomatic hepatitis C virus infection in Egyptian children.

M S El-Raziky1, M El-Hawary, G Esmat, A M Abouzied, N El-Koofy, N Mohsen, S Mansour, A Shaheen, M Abdel Hamid, H El-Karaksy.   

Abstract

AIM: To identify the prevalence, risk factors and manifestations of asymptomatic hepatitis C virus (HCV) infection in Egyptian children.
METHODS: Children at the age of 1-9 years were screened for HCV antibodies and alanine aminotransferase (ALT) levels. Every child with elevated ALT and/or detectable HCV antibodies was tested for HCV RNA by RT-PCR and compared with two negative controls for risk factors and signs and symptoms of liver disease.
RESULTS: We screened 1042 children, six of them had elevated ALT, negative HCV antibody and positive RNA, likely representing acute hepatitis C cases. Fifteen children were HCV seropositive, 5 of them were HCV RNA positive. Asymptomatic HCV infection was present in 2.02% (positive results for either HCV antibodies or HCV-RNA or both). Symptoms such as diarrhea, abdominal pain, history of fatigue and school absence because of illness and risk factors such as dental care were significantly more common among HCV positive cases than among controls. None of the HCV positive children was diagnosed as having signs of advanced liver disease upon clinical or ultrasonographic examination.
CONCLUSION: Asymptomatic HCV infection is detectable in 2.02% Egyptian children.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17465475      PMCID: PMC4149961          DOI: 10.3748/wjg.v13.i12.1828

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.

Authors:  M Vogt; T Lang; G Frösner; C Klingler; A F Sendl; A Zeller; B Wiebecke; B Langer; H Meisner; J Hess
Journal:  N Engl J Med       Date:  1999-09-16       Impact factor: 91.245

2.  Optimization, assessment, and proposed use of a direct nested reverse transcription-polymerase chain reaction protocol for the detection of hepatitis C virus.

Authors:  M Abdel-Hamid; D C Edelman; W E Highsmith; N T Constantine
Journal:  J Hum Virol       Date:  1997 Nov-Dec

3.  Changing epidemiologic pattern of chronic hepatitis C virus infection in Italian children.

Authors:  F Bortolotti; M Resti; R Giacchino; C Crivellaro; L Zancan; C Azzari; N Gussetti; L Tasso; S Faggion
Journal:  J Pediatr       Date:  1998-09       Impact factor: 4.406

Review 4.  Transmission, natural history, and treatment of hepatitis C virus infection in the pediatric population.

Authors:  J B Schwimmer; W F Balistreri
Journal:  Semin Liver Dis       Date:  2000       Impact factor: 6.115

5.  Prevalence and manifestations of hepatitis C seropositivity in children in an endemic area.

Authors:  S N Lu; H C Chen; C M Tang; M H Wu; M L Yu; W L Chuang; C F Lu; W Y Chang; C J Chen
Journal:  Pediatr Infect Dis J       Date:  1998-02       Impact factor: 2.129

6.  HCV-related morbidity in a rural community of Egypt.

Authors:  Mostafa K Mohamed; Iman Bakr; Mostafa El-Hoseiny; Naglaa Arafa; Abubakr Hassan; Soheir Ismail; Mohamed Anwar; Mohamed Attala; Claire Rekacewicz; Khaled Zalata; Mohamed Abdel-Hamid; Gamal Esmat; Arnaud Fontanet
Journal:  J Med Virol       Date:  2006-09       Impact factor: 2.327

7.  Hepatitis c in a community in Upper Egypt: risk factors for infection.

Authors:  Ahmed Medhat; Magda Shehata; Laurence S Magder; Nabiel Mikhail; Laila Abdel-Baki; Mohamed Nafeh; Mohamed Abdel-Hamid; G Thomas Strickland; Alan D Fix
Journal:  Am J Trop Med Hyg       Date:  2002-05       Impact factor: 2.345

8.  Hepatitis C virus infection in Egyptian children: single centre experience.

Authors:  M S El-Raziky; M El-Hawary; N El-Koofy; S Okasha; M Kotb; K Salama; G Esmat; M El-Raziky; A M Abouzied; H El-Karaksy
Journal:  J Viral Hepat       Date:  2004-09       Impact factor: 3.728

9.  The epidemiology of Schistosoma mansoni, hepatitis B and hepatitis C infection in Egypt.

Authors:  M A Kamel; F D Miller; A G el Masry; S Zakaria; M Khattab; G Essmat; Y A Ghaffar
Journal:  Ann Trop Med Parasitol       Date:  1994-10

10.  Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region.

Authors:  F Davidson; P Simmonds; J C Ferguson; L M Jarvis; B C Dow; E A Follett; C R Seed; T Krusius; C Lin; G A Medgyesi
Journal:  J Gen Virol       Date:  1995-05       Impact factor: 3.891

View more
  16 in total

1.  Serum complement C4a and its relation to liver fibrosis in children with chronic hepatitis C.

Authors:  Behairy E Behairy; Ghada M El-Mashad; Ragab S Abd-Elghany; Enas M Ghoneim; Mostafa M Sira
Journal:  World J Hepatol       Date:  2013-08-27

2.  Pegylated interferon α/ribavirin therapy enhances bone mineral density in children with chronic genotype 4 HCV infection.

Authors:  Ahmed Megahed; Nanees Salem; Abeer Fathy; Tarik Barakat; Mona Abd El Latif Alsayed; Suzy Abd El Mabood; Khaled R Zalata; Ahmed F Abdalla
Journal:  World J Pediatr       Date:  2017-01-27       Impact factor: 2.764

Review 3.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children.

Authors:  Suzan El Naghi; Tawhida Y Abdel-Ghaffar; Hanaa El-Karaksy; Elham F Abdel-Aty; Mona S El-Raziky; Aleef A Allam; Heba Helmy; Hanaa A El-Araby; Behairy E Behairy; Mohamed A El-Guindi; Hatem El-Sebaie; Aisha Y Abdel-Ghaffar; Nermin A Ehsan; Ahmed M El-Hennawy; Mostafa M Sira
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

5.  Risk factors for hepatitis C virus acquisition and predictors of persistence among Egyptian children.

Authors:  Gamal Esmat; Mohamed Hashem; Mona El-Raziky; Wafaa El-Akel; Suzan El-Naghy; Nehal El-Koofy; Rokaya El-Sayed; Rasha Ahmed; Mohamed Atta-Allah; Mohamed Abdel Hamid; Samer S El-Kamary; Hanaa El-Karaksy
Journal:  Liver Int       Date:  2011-09-15       Impact factor: 5.828

6.  Epidemiology of hepatitis C virus exposure in Egypt: Opportunities for prevention and evaluation.

Authors:  F DeWolfe Miller; Mahmoud S Elzalabany; Sara Hassani; Diego F Cuadros
Journal:  World J Hepatol       Date:  2015-12-08

Review 7.  The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis.

Authors:  Yousra A Mohamoud; Ghina R Mumtaz; Suzanne Riome; Dewolfe Miller; Laith J Abu-Raddad
Journal:  BMC Infect Dis       Date:  2013-06-24       Impact factor: 3.090

8.  Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9-12 years) and adolescents.

Authors:  Hanaa A El-Araby; Behairy E Behairy; Mohamed A El-Guindi; Nermin M Adawy; Alif A Allam; Ahmad M Sira; Mohamed A Khedr; Ibrahim A Elhenawy; Gihan A Sobhy; Hosam El Din M Basiouny; Menan E Salem; Samira A Abdel-Aziz; Ola A Fouad; Bassam A Ayoub
Journal:  Hepatol Int       Date:  2019-09-12       Impact factor: 9.029

9.  The impact of interleukin 28b gene polymorphism on the virological response to combined pegylated interferon and ribavirin therapy in chronic HCV genotype 4 infected egyptian patients using data mining analysis.

Authors:  Marwa Khairy; Rabab Fouad; Mahassen Mabrouk; Wafaa El-Akel; Abu Bakr Awad; Rabab Salama; Mayada Elnegouly; Olfat Shaker
Journal:  Hepat Mon       Date:  2013-07-17       Impact factor: 0.660

10.  Hepatitis C virus infection in Egyptian children with type 1 diabetes mellitus: A single center study.

Authors:  Hekma Saad Farghaly; Kotb Abbass Metwalley; Heba Ahmed Abd El-Hafeez
Journal:  Indian J Endocrinol Metab       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.